Draft genome sequence of a multidrug-resistant <i>Mycobacterium tuberculosis</i> clinical isolate, 3184-KZ-Reference-Cited by-同舟云学术

Draft genome sequence of a multidrug-resistant Mycobacterium tuberculosis clinical isolate, 3184-KZ

Published:2023-12-14 Issue:12 Volume:12 Page:
ISSN:2576-098X
Container-title:Microbiology Resource Announcements
language:en
Short-container-title:Microbiol Resour Announc

Author:

Auganova Dana¹,Atavliyeva Sabina¹,Akisheva Akmaral²,Tsepke Anna²,Tarlykov Pavel¹^ORCID

Affiliation:

1. Core Facility of Genomics and Proteomics, National Center for Biotechnology, Astana, Kazakhstan

2. Clinical Bacteriological Laboratory, City Center for Phthisiopulmonology of the Akimat of Astana, Astana, Kazakhstan

Abstract

ABSTRACT Mycobacterium tuberculosis is an obligate aerobic bacterium that is the causative agent of tuberculosis. Here, we announce the draft genome sequence of multidrug-resistant Mycobacterium tuberculosis clinical isolate, 3184-KZ, from a patient with infiltrative pulmonary tuberculosis from Kazakhstan.

Funder

Science Committee of the Ministry of Science and Higher Education

Publisher

American Society for Microbiology

Subject

Genetics,Immunology and Microbiology (miscellaneous),Molecular Biology

Link

https://journals.asm.org/doi/pdf/10.1128/mra.00863-23

Reference17 articles.

1. World Health O. 2020. Meeting report of the WHO expert consultation on the definition of extensively drug-resistant tuberculosis. World Health Organization, Geneva.

2. World Health O. 2022. Global tuberculosis report 2022. World Health Organization, Geneva.

3. Whole-Genome Sequence-Based Characterization of Pre-XDR M. tuberculosis Clinical Isolates Collected in Kazakhstan

4. Genomic Analysis of Multidrug-Resistant Mycobacterium tuberculosis Strains From Patients in Kazakhstan

5. Draft Genome Sequence of an Extensively Drug-Resistant Mycobacterium tuberculosis Clinical Isolate, 3485_MTB, from Nur-Sultan, Kazakhstan